Literature DB >> 837535

Urinary free norepinephrine and dopamine determined by reverse-phase high-pressure liquid chromatography.

L D Mell, A B Gustafson.   

Abstract

We used reverse-phase high-pressure liquid chromatography to measure free norepinephrine and dopamine simultaneously in human urine. Samples were treated with alumina, and the catecholamine(s) then eluted from it were directly injected onto a reverse-phase column (octadecyl-silica stationary phase), with 0.17 mol/liter acetic acid as the mobile phase and ultraviolet detection at 280 nm. The assay detects concentrations in urine as low as 5 mug/liter. Assay of 24-h urines (n = 10) gave within-run and day-to-day coefficients of variation of 3.7 and 4.7% for norepinephrine, and 2.6 and 3.5% for dopamine, respectively. Comparison studies with the traditional trihydroxyindole fluorometric method showed the liquid-chromatographic procedure to be more precise and subject to less interference. This relatively rapid procedure for urinary free norepinephrine and dopamine provides an efficient, reproducible method, readily adaptable to routine clinical use.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837535

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Failure of ascorbic acid to influence brain catecholamines in the guinea-pig.

Authors:  M D Green; W Bell; C Kraut; S Omaye
Journal:  Experientia       Date:  1979-04-15

2.  Determination of plasma catecholamines by means of radioenzymatic labelling and high pressure liquid chromatographic separation.

Authors:  E Appel; P Bayer; P Hajdú; D Palm; J Schofer; M Uihlein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-01       Impact factor: 3.000

3.  Endogenously produced catecholamines improve the regulatory function of TLR9-activated B cells.

Authors:  Nadine Honke; Torsten Lowin; Birgit Opgenoorth; Namir Shaabani; Alexander Lautwein; John R Teijaro; Matthias Schneider; Georg Pongratz
Journal:  PLoS Biol       Date:  2022-01-24       Impact factor: 8.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.